In a letter to Dr Rosemary Biggs, Dr Cumming noted that there was no valid reason for a shortage of "coagulation factor" products, and that recent results from frozen plasma used in the production of concentrate meant that cryoprecipitate use would decline as centralised production by other methods was feasible.